NovaBay Pharmaceuticals Inc (NBY) — Cash Flow-to-Debt Ratio
NovaBay Pharmaceuticals Inc (NBY) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of $-2.27 Million could theoretically repay 0% of its total liabilities ($31.86 Million) in one year. Check NBY total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NovaBay Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for NovaBay Pharmaceuticals Inc across 21 annual periods. Also explore balance sheet size of NovaBay Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for NovaBay Pharmaceuticals Inc (2005–2025)
Year-by-year debt coverage analysis for NovaBay Pharmaceuticals Inc. For market capitalisation and broader financial context, see how much is NovaBay Pharmaceuticals Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.26x | $-8.43 Million | $31.86 Million | ▲ +81.9% |
| 2024 | -1.46x | $-5.18 Million | $3.55 Million | ▼ -95.9% |
| 2023 | -0.74x | $-4.26 Million | $5.72 Million | ▲ +34.6% |
| 2022 | -1.14x | $-6.65 Million | $5.84 Million | ▼ -71.0% |
| 2021 | -0.67x | $-9.19 Million | $13.81 Million | ▲ +58.8% |
| 2020 | -1.62x | $-4.72 Million | $2.92 Million | ▼ -108.9% |
| 2019 | -0.77x | $-7.93 Million | $10.25 Million | ▲ +38.8% |
| 2018 | -1.26x | $-5.57 Million | $4.41 Million | ▼ -50.8% |
| 2017 | -0.84x | $-6.27 Million | $7.49 Million | ▲ +42.8% |
| 2016 | -1.47x | $-12.13 Million | $8.28 Million | ▲ +19.6% |
| 2015 | -1.82x | $-18.56 Million | $10.18 Million | ▲ +31.1% |
| 2014 | -2.65x | $-15.05 Million | $5.69 Million | ▼ -45.6% |
| 2013 | -1.82x | $-12.97 Million | $7.13 Million | ▼ -44.4% |
| 2012 | -1.26x | $-6.53 Million | $5.19 Million | ▼ -165.2% |
| 2011 | -0.47x | $-3.14 Million | $6.62 Million | ▼ -217.6% |
| 2010 | 0.40x | $2.03 Million | $5.03 Million | ▲ +202.3% |
| 2009 | -0.39x | $-1.65 Million | $4.18 Million | ▲ +73.7% |
| 2008 | -1.50x | $-9.94 Million | $6.62 Million | ▼ -129.8% |
| 2007 | -0.65x | $-6.27 Million | $9.60 Million | ▼ -238.4% |
| 2006 | 0.47x | $4.74 Million | $10.05 Million | ▲ +104.5% |
| 2005 | -10.42x | $-3.23 Million | $310.00K | — |